Patents by Inventor Josef Georg Heuer

Josef Georg Heuer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of LP82 to treat hematopoietic disorders
    Patent number: 7101539
    Abstract: The present invention relates to a method of using a mammalian gene sequence and polypeptides encoded thereby to treat mammalian hematopoietic disorders. More specifically the present invention relates to methods of using compositions comprising at least one LP82 agonist, LP82 antagonist, LP82 polynucleotide, LP82 polypeptide, and/or LP82 antibody for the prevention and/or treatment of mammalian hematopoietic disorders, including, but not limited to, anemia, leukemia, and hematopoietic conditions caused by bone marrow transplantation or chemo-/radiation therapy.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: September 5, 2006
    Assignee: Eli Lilly and Company
    Inventors: Josef Georg Heuer, Ling Liu, Timothy W. Noblitt
  • Novel polypeptide analogs and fusions and their methods of use
    Publication number: 20040236088
    Abstract: Novel polypeptide analogs and fusion proteins of a transmembrane protein, LP276, are provided. Vectors and host cells directed to these polypeptides are provided. Additionally, methods of use are provided for the treatment or prevention of allergic autoimmune diseases, type 1 diabetes, inflammation, immunodeficiencies, cancers, and infectious diseases by administering an LP276 polypeptide, analogs and fusion proteins thereof to a patient in need of such therapy.
    Type: Application
    Filed: January 15, 2004
    Publication date: November 25, 2004
    Inventors: Josef Georg Heuer, Songqing Na, Angela Jeannine Okragly, Weijia Ou
  • Lp mammalian proteins; related reagents
    Publication number: 20040126777
    Abstract: Isolated nucleic acid molecules encoding polypeptides from a human, reagents related thereto (including purified polypeptidesspecific antibodies) are provided. Methods of using said reagentsand diagnostic kits are also provided.
    Type: Application
    Filed: July 25, 2003
    Publication date: July 1, 2004
    Inventors: Ramesh Rajani Bhatt, John Nels Calley, Josef Georg Heuer, Gerald Patrick Keleher, Joanne Sloan Lancaster, Qingqin Li, Deshun Lu, Bradley Jay Mills, Santosh Kumar Mishra, Douglas Raymond Perkins, Scott William Rowlinson, Rosamund Carol Smith, Eric Wen Su, He Wang, Yu Zhi
  • Use of LP82 to treat hematopoietic disorders
    Publication number: 20040092445
    Abstract: The present invention relates to a method of using a mammalian gene sequence and polypeptides encoded thereby to treat mammalian hematopoietic disorders. More specifically the present invention relates to methods of using compositions comprising at least one LP82 agonist, LP82 antagonist, LP82 polynucleotide, LP82 polypeptide, and/or LP82 antibody for the prevention and/or treatment of mammalian hematopoietic disorders, including, but not limited to, anemia, leukemia, and hematopoietic conditions caused by bone marrow transplantation or chemo-/radiation therapy.
    Type: Application
    Filed: August 6, 2003
    Publication date: May 13, 2004
    Inventors: Josef Georg Heuer, Ling Liu, Timothy W Noblitt
  • Therapeutic methods of use for lp229
    Publication number: 20040072745
    Abstract: Methods of use are provided for the treatment or prevention of poor healing or chronic wounds, skin diseases, sepsis, inflammation, immunodeficiencies, autoimmune diseases, infectious diseases, allergic diseases, and malignancies, particularly those disorders associated with the skin, by administering an LP229 polypeptide, protein, or epitope-recognizing antibody thereof to a patient in need of such therapy.
    Type: Application
    Filed: July 8, 2003
    Publication date: April 15, 2004
    Inventors: Josef Georg Heuer, Kristine Kay Kikly, Eric Wen Su
  • Treating t-cell mediated diseases by modulating dr6 activity
    Publication number: 20040043022
    Abstract: Novel methods are provided for the treatment or prevention of T cell mediated conditions in a mammal that comprise administering to said mammal a therapeutically effective amount of a pharmaceutical composition comprising at least one DR6 agonist or DR6 antagonist.
    Type: Application
    Filed: October 16, 2002
    Publication date: March 4, 2004
    Inventors: Josef Georg Heuer, Jinqi Liu, Songqing Na, Ho Yeong Song, Derek Di Yang